SCI时时刷

search
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation
Exploratory longitudinal cohort studyStudy designWe prospectively collected serum samples of patients with advanced solid ...
Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy
BackgroundToll-like receptors (TLRs) are evolutionarily conserved receptors, the largest constituents of the pattern recog...
CCR5 and CCL5 in metastatic colorectal cancer
The C-C motif chemokine receptor and ligand type 5 (CCR5 and CCL5, respectively) axis is a well-described pathway in immun...
Preliminary efficacy and safety of YSCH-01 in patients with advanced solid tumors: an investigator-initiated trial
IntroductionCancer is a leading global cause of mortality, accounting for nearly 10.0 million deaths, or approximately one...
Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis
IntroductionImmune evasion plays a key role in tumor progression, which implies that tumors have potential to establish co...
CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma
WHAT IS ALREADY KNOWN ON THIS TOPICGlioblastoma (GBM) immunotherapy resistance has been linked primarily to a deficiency i...
Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity
BackgroundAlthough immunotherapy, especially immune checkpoint inhibitors, has shown clinical success, its efficacy is oft...
Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway
BackgroundImmune checkpoint inhibitors (ICIs) mainly include antibodies that targeting programmed cell death protein-1 (PD...
Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions
WHAT IS ALREADY KNOWN ON THIS TOPICAntibody-mediated targeting of CD1d on multiple myeloma cells was reported to induce an...
Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
Balaji A, Hsu M, Lin CT, et al. Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outco...
Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication
IntroductionImmunotherapy has revolutionized cancer treatment, with durable antitumor responses in a subgroup of patients....
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
BackgroundHepatocellular carcinoma (HCC) is a malignant tumor and has the fifth highest incidence rate and the second high...
MDSCs-derived GPR84 induces CD8+ T-cell senescence via p53 activation to suppress the antitumor response
IntroductionMyeloid-derived suppressor cells (MDSCs) are a heterogeneous population of suppressive innate immune cells, in...